Viewing StudyNCT01206088



Ignite Creation Date: 2024-05-05 @ 10:53 PM
Last Modification Date: 2024-10-26 @ 10:25 AM
Study NCT ID: NCT01206088
Status: COMPLETED
Last Update Posted: 2017-02-28
First Post: 2010-09-20

Brief Title: Tasigna in Glivec-resistant or Intolerant Patients in CML
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Imatinib Intolerant
CML
Nilotinib
Imatinib Resistant
Keywords: